Systematic Ambulatory ECG Monitoring Following TAVI
NCT07739316
Aortic Stenosis, Aortic Valve Disease
Québec, Quebec, Canada
View Trial DetailsNCT Number: NCT06255691
There is a lack of data on patients self-reported outcomes (PROMs) on health-related quality of life (HRQoL)and symptoms on anxiety and depression 10 years after Surgical After Aortic Valve Replacement (SAVR), and patient reported experiences with the health services (PREMS). In this 10-years follow-up study on patients alive from the study named "The Impact of 24/ 7-phone Support on Readmission After Aortic Valve Replacement, a Randomized Clinical Trial (AVRre)" NCT02522663 we will repeat the survey on symtoms on anxiety and depresion using Hospital Anxiety and depression Scale (HADS), health-related quality of life (EQ-5D) and questions about experiences with the health services.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
"The Impact of 24/ 7-phone Support on Readmission After Aortic Valve Replacement, a Randomized Clinical Trial (AVRre) was a prospective, randomized controlled study (RSC) Including 286 patients after AVR from 2015 til 2017, NCT02522663. The results reported in international publications showed reduced symptoms on anxiety the first month after AVR.
Reduction of anxiety revealed to be an important aim for the intervention. We found that symptoms of anxiety in the early rehabilitation phase after discharge following surgical aortic valve replacement phase was significantly reduced.
There is a lack of data on patients self-reported outcome on symptoms on anxiety and depression 10 years after Surgical After Aortic Valve Replacement (SAVR), and patient reported experiences with health services. In this 10-years follow-up study on patients alive from the study named "The Impact of 24/ 7-phone Support on Readmission After Aortic Valve Replacement, a Randomized Clinical Trial (AVRre)" NCT02522663 we will conduct a survey on symtoms of anxiety and depresion using Hospital Anxiety and depression Scale (HADS), quality of life (EQ-5D) and questions about experiences with health services.
The results of the planned 10-years follow-up may give guidance in how to allocate health resources and planning for and follow-up of patients after heart surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Treatment with AVR (biological or mechanical) single, AVR (b or m)+aortocoronary bypass, AVR (b or m)+supra coronary tube graft Can understand, speak and write native Language (norwegian), and be able to fill in the questionnaires
-
Exclusion criteria
Patients not alive after the AVRre study
Time frame: 10 year follow-up
Symptoms of anxiety and depression measured by Hospital Anxiety and Depression Scale (HADS)
Time frame: 10 year follow-up
EQ-5D-3L questionnaire from The EuroQol Group to measure health related quality of life.
Time frame: 10 year follow-up
Open questions
Contact information is provided by the study sponsor or research team.
Irene Lie, PhD
CONTACT
Stein O Danielsen, PhD
CONTACT
Oslo University Hospital
Other
10-year Follow-up After 24/7-phone Support After Aortic Valve Replacement Surgery in Early Rehabilitation Study
Acronym: AVR-10year
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07739316
Aortic Stenosis, Aortic Valve Disease
Québec, Quebec, Canada
View Trial DetailsNCT07738575
Aortic Stenosis, Aortic Stenosis, Severe
Québec, Quebec, Canada
View Trial DetailsNCT07539259
Aortic Stenosis, Aortic Valve Disease
View Trial DetailsNCT07690748
Aortic Stenosis, Aortic Valve Disease
View Trial Details